6-苯氧基-3-吡啶异硫氰酸 - CAS号 52024-70-1

物化性质

熔点：

41 °C
沸点：

374.9±27.0 °C(Predicted)
密度：

1.18±0.1 g/cm3(Predicted)

计算性质

辛醇/水分配系数(LogP)：

4.1
重原子数：

16
可旋转键数：

3
环数：

2.0
sp3杂化的碳原子比例：

0.0
拓扑面积：

66.6
氢给体数：

0
氢受体数：

4

安全信息

危险品标志：

Xn
安全说明：

S26,S36/37/39
危险类别码：

R20/21/22,R36/37/38
海关编码：

2933399090
危险品运输编号：

UN 2811

SDS

SDS：138ffeb0821872660bac342b2501cff7

查看

Name:	6-Phenoxy-3-pyridinyl isothiocyanate 97% Material Safety Data Sheet
Synonym:
CAS:	52024-70-1

Section 1 - Chemical Product MSDS Name:6-Phenoxy-3-pyridinyl isothiocyanate 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
52024-70-1	6-Phenoxy-3-pyridinyl isothiocyanate	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 52024-70-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: characteristic odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 40 - 43 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C12H8N2OS
Molecular Weight: 228.27

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, bases, amines, reducing agents, acids.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 52024-70-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
6-Phenoxy-3-pyridinyl isothiocyanate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 52024-70-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 52024-70-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 52024-70-1 is not listed on the TSCA inventory.
It is for research and development use only.

SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

上游原料

中文名称英文名称 CAS号化学式分子量

6-苯氧基-3-吡啶胺 6-phenoxy-pyridin-3-ylamine 25194-67-6 C₁₁H₁₀N₂O 186.213

中文名称	英文名称	CAS号	化学式	分子量
6-苯氧基-3-吡啶胺	6-phenoxy-pyridin-3-ylamine	25194-67-6	C₁₁H₁₀N₂O	186.213

反应信息

作为反应物：

描述：

9a-(3-aminopropyl)-9-deoxo-9a-aza-9a-homoerythromycin A 、 6-苯氧基-3-吡啶异硫氰酸以二氯甲烷为溶剂，反应 48.0h，生成 1-[3-[(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadec-6-yl]propyl]-3-(6-phenoxypyridin-3-yl)thiourea

参考文献：

名称：

一种自动化的聚合物辅助策略，可制备15元氮杂内酯的尿素和硫脲衍生物，作为潜在的抗疟疾化学疗法

摘要：

合成了一系列15元氮杂内酰胺脲和硫脲衍生物，并评估了它们对恶性疟原虫的氯喹敏感性（D6），氯喹/乙胺嘧啶抗性（W2）和多药耐药性（TM91C235）菌株的体外抗疟活性。我们已经开发出一种有效的自动化合成策略，用于大环内酯支架的尿素/硫脲库的快速合成。使用溶液相策略合成化合物，总收率为50–80％。大多数合成的化合物具有抑制作用。前三种化合物对所有三种菌株的效力比阿奇霉素高30-65倍，阿奇霉素具有抗疟疾活性。

DOI：

10.1016/j.bmc.2011.01.030
作为产物：

描述：

6-苯氧基-3-吡啶胺、硫光气以 1,4-二氧六环、 (2S)-N-methyl-1-phenylpropan-2-amine hydrate 为溶剂，生成 6-苯氧基-3-吡啶异硫氰酸

参考文献：

名称：

Isothiocyanopyridine derivatives

摘要：

新异硫氰基吡啶的化学式为 ##STR1## 其中 R.sub.1 代表氢、烷基、取代烷基、环烷基、环烯基，或者化学式 ##STR2## 其中 R.sub.3、R.sub.4 和 R.sub.5 代表氢、烷基、苯基、苄基、二烷基氨基、烷氧羰基、单烷基或二烷基氨基甲酰基、烷酰基、卤素、硝基、烷氧基、烷基硫基、卤代烷基、氰基、羟基、芳基氧基、芳基硫基、芳基氨基、芳烷氧基、芳烷硫基或芳基氨基，Q 代表 0 到 6，X 代表氧、硫、磺酰基或化学式 ##STR3## 其中 R.sub.6 代表氢、烷基、烯基、二烷基氨基烷基、烷氧羰基、烷酰基，或者与氮原子和取代基 R.sub.1 一起代表饱和或不饱和杂环，该杂环可以进一步包含氧、硫、氮或化学式 N-R.sub.7，其中 R.sub.7 代表氢、甲基或乙基，R.sub.2 代表氢或卤素，每个符号 m 和 n 中的一个表示为 1 而另一个表示为 0，以及它们对于温血动物无毒的酸盐和季铵盐。

公开号：

US04001254A1

点击查看最新优质反应信息

文献信息

[EN] Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R)<br/>[FR] UREE-OCTAHYDROINDOLES SUBSTITUES UTILISES EN TANT QU'ANTAGONISTES DU RECEPTEUR 1 DE L'HORMONE CONCENTRANT LA MELANINE (MCH1R)

申请人：BIOVITRUM AB

公开号：WO2005051381A1

公开（公告）日：2005-06-09

The invention relates to compounds of the general formula (I) wherein R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, Ar, and X are as defined in the description, or a pharmaceutically acceptable salt, hydrates, geometrical isomers, racemates, tautomers, optical isomers, N-oxides and prodrug forms thereof. The compounds may be used for the treatment or prophylaxis of disorders related to the MCH1R receptor and for modulation of appetite. The invention also relates to such use as well as to pharmaceutical formulations comprising a compound of formula (I).

该发明涉及通式（I）的化合物，其中R0、R1、R2、R3、R4、R5、R6、R7、R8、R9、Ar和X如描述中所定义，或其药学上可接受的盐、水合物、几何异构体、消旋体、互变异构体、光学异构体、N-氧化物及其前药形式。这些化合物可用于治疗或预防与MCH1R受体相关的疾病，并用于调节食欲。该发明还涉及该用途以及包含通式（I）化合物的药物配方。
Novel Antimalarial 9A-Carbamoyl-Aminoalkyl and 9A-Thiocarbamoyl-Aminoalkyl Azalides

申请人：Bukvic Krajacic Mirjana

公开号：US20080200404A1

公开（公告）日：2008-08-21

Novel 9a-N′-substituted-carbamoyl- and thiocarbamoyl-aminoalkyl-9a-aza-9-deoxo-9-dihydro-9a-homoerythromycin A and 3-O-decladinosyl-9a-aza-9-deoxo-9-dihydro-9a-homoerythromycin A compounds having antimalarial activity are claimed. More particularly, the invention relates to 9a-N′-substituted-carbamoyl- and thiocarbamoyl-β-aminoethyl- or -γ-aminopropyl-9a-aza-9-deoxo-9-dihydro-9a-homoerythromycin A and 3-O-decladinosyl-9a-aza-9-deoxo-9-dihydro-9a-homoerythromycin A compounds and to pharmaceutically acceptable derivatives thereof having antimalarial activity.

本发明涉及具有抗疟活性的9a-N'-取代-氨基甲酰基和硫代氨基甲酰基-氨基烷基-9a-氮杂-9-去氧-9-二氢-9a-同源红霉素A和3-O-去氯基-9a-氮杂-9-去氧-9-二氢-9a-同源红霉素A化合物。更具体地，该发明涉及具有抗疟活性的9a-N'-取代-氨基甲酰基和硫代氨基甲酰基-β-氨基乙基或-γ-氨基丙基-9a-氮杂-9-去氧-9-二氢-9a-同源红霉素A和3-O-去氯基-9a-氮杂-9-去氧-9-二氢-9a-同源红霉素A化合物及其具有抗疟活性的药用可接受衍生物。
New compounds

申请人：Browning Andrew

公开号：US20050239841A1

公开（公告）日：2005-10-27

The invention relates to compounds of the general formula (I) wherein R 0 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , Ar, and X are as defined in the description, or a pharmaceutically acceptable salt, hydrates, geometrical isomers, racemates, tautomers, optical isomers, N-oxides and prodrug forms thereof. The compounds may be used for the treatment or prophylaxis of disorders related to the MCH1R receptor and for modulation of appetite. The invention also relates to such use as well as to pharmaceutical formulations comprising a compound of formula (I).

本发明涉及一般式（I）的化合物，其中R0，R1，R2，R3，R4，R5，R6，R7，R8，R9，Ar和X如描述中所定义，或其药学上可接受的盐，水合物，几何异构体，外消旋体，互变异构体，光学异构体，N-氧化物和前药形式。该化合物可用于治疗或预防与MCH1R受体相关的疾病，并用于调节食欲。本发明还涉及此类用途，以及包含式（I）化合物的制药配方。
US4001254A

申请人：——

公开号：US4001254A

公开（公告）日：1977-01-04
An automated, polymer-assisted strategy for the preparation of urea and thiourea derivatives of 15-membered azalides as potential antimalarial chemotherapeutics

作者：Antun Hutinec、Renata Rupčić、Dinko Žiher、Kirsten S. Smith、Wilbur Milhous、William Ellis、Colin Ohrt、Zrinka Ivezić Schönfeld

DOI：10.1016/j.bmc.2011.01.030

日期：2011.3

series of 15-membered azalide urea and thiourea derivatives has been synthesized and evaluated for their in vitro antimalarial activity against chloroquine-sensitive (D6), chloroquine/pyremethamine resistant (W2) and multidrug resistant (TM91C235) strains of Plasmodium falciparum. We have developed an effective automated synthetic strategy for the rapid synthesis of urea/thiourea libraries of a macrolide

合成了一系列15元氮杂内酰胺脲和硫脲衍生物，并评估了它们对恶性疟原虫的氯喹敏感性（D6），氯喹/乙胺嘧啶抗性（W2）和多药耐药性（TM91C235）菌株的体外抗疟活性。我们已经开发出一种有效的自动化合成策略，用于大环内酯支架的尿素/硫脲库的快速合成。使用溶液相策略合成化合物，总收率为50–80％。大多数合成的化合物具有抑制作用。前三种化合物对所有三种菌株的效力比阿奇霉素高30-65倍，阿奇霉素具有抗疟疾活性。

6-苯氧基-3-吡啶异硫氰酸 | 52024-70-1

分子结构分类

物化性质

计算性质

安全信息

SDS

上下游信息

反应信息

文献信息

同类化合物

相关结构分类

热门分子